ACM Research Inc.'s operating subsidiary, ACM Research (Shanghai), Inc., has received significant regulatory approval from the China Securities Regulatory Commission (CSRC) for its proposed private offering of ordinary shares. Announced on June 28, 2025, this approval allows ACM Shanghai to proceed with the offering within the next 12 months. The private offering, initially disclosed in January 2024, permits the issuance of up to 10% of ACM Shanghai's share capital, now updated to 44.1 million ordinary shares. This move is expected to generate gross proceeds of up to RMB 4.5 billion, approximately $625 million, reflecting the company's recent exercise of employee stock options. There is no indication that any other organizations are involved in this specific offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.